Global Cancer Vaccines Market 2015-2019

[email protected]

Global Cancer Vaccines Market 2015-2019

Covered in this Report

• This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019.

• To calculate the market size, the report considers revenue generated from the sales of various therapeutic and prophylactic cancer vaccines.

• The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market.

• In addition, it discusses the major drivers that influence the growth of the market.

• Technavio's report, Global Cancer Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Global Cancer Vaccines Market

2015-2019

USA – CANADA – UK – CHINA – INDIA

Market Overview• Cancer vaccines are biological preparations that

stimulate or strengthen a person’s immune system against cancer.

• Cancer vaccines are usually administered intravenously.

• They can be used in both adults and children.

• The vaccines can be broadly classified into two: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of cancer.

• Technavio's analysts forecast the global cancer vaccines market to grow at a CAGR of 27.24% over the period 2014-2019.

To know more aboutGlobal Cancer Vaccines

Market 2015-2019,please mail us at

[email protected]

USA – CANADA – UK – CHINA – INDIA

Key Vendors and Regions

• Dendreon• • laxoSmithKline

• Merck

• Aduro BioTech

• Advantagene

• Advaxis

• Agenus

• AlphaVax

View Our Report: Global Cancer Vaccines Market 2015-2019

• Americas

• APAC

• EMEA

Vendors Regions

USA – CANADA – UK – CHINA – INDIA

Key Findings

USA – CANADA – UK – CHINA – INDIA

• Physicians prefer a combination of cancer vaccines with pharmacotherapeutics to treat cancer.

• This not only increases the efficacy of the treatment but also helps improve the overall survival rate of patients.

• These vaccines are also combined with adjuvants to enhance their performance.

• Provenge is administered along with dendritic cells to patients.

• These cells produce an enhanced immune response against the malignant cells in the body and stimulate the other cells in the immune system to fight the cancerous cells.

• Vaccine manufacturers are shifting their bases to developing countries to utilize the favorable business conditions in these countries.

• The availability of skilled manpower, excellent manufacturing capabilities, and low production costs make countries such as India and China vaccine-development hubs.

• Hence, this shift toward emerging markets is expected to propel market growth.

Key Questions Answered in Our Report

• What will the market size be in 2019 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Have a question of your own about this report?

Ask our Analysts

USA – CANADA – UK – CHINA – INDIA

• Decision makers and influencers in sales & marketing, strategy, product and R&D teams rely on research from Technavio. We have a large and growing base of happy customers worldwide. Our customers include technology suppliers, end users, consulting companies, investment firms and research institutes.

• Technavio was founded in 2003 in London. We have about 300 analysts globally. We cover more than 500 technologies across 80 countries. Traditional media such as Forbes Asia and New York Times, along with other web media portals, like to quote us.

About Technavio

Some of our clients include:ACT Global, Flextronics, Huawei Technologies Co, Infosys, Harris Corporation, Infosys, Intercad, Hidaka Precision Tools & Dies Company, Huawei Technologies Co, American Capital, Analysis Group, Netscout, NTT DoCoMo

USA – CANADA – UK – CHINA – INDIA

View Our Report

Global Cancer Vaccines Market 2015-2019

65 Pages | SKU: IRTNTR6198

For media enquiries,

please drop us a mail at

[email protected]

For more on the scope of the report, mail us at

[email protected]

Thank You!

Mail us at: [email protected] can visit us at:www.technavio.com

USA – CANADA – UK – CHINA – INDIA